» Articles » PMID: 17610553

Long-term Major Joint Outcomes in Young Adults with Haemophilia: Interim Data from the HGDS

Overview
Journal Haemophilia
Specialty Hematology
Date 2007 Jul 6
PMID 17610553
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

A study of major joint outcomes, specifically range of motion and synovitis, was conducted with data from a subset of adolescents enrolled in the prospective Hemophilia Growth and Development Study (HGDS). Clinical observations were carried out over a 7-year period from 1989 to 1996. A secondary aim was to gain insight into factors that might influence decisions regarding maintaining or discontinuing prophylaxis during early adulthood. Twenty-nine participants (median age 17.4 at entry) were included. Median follow-up was 7 years (range: 4.8-7.7). Range of motion (ROM) and synovitis in six major joints (knees, elbows and ankles), were evaluated by physical examination every 6-12 months. At the baseline observation, 73.6% of joints showed no ROM abnormalities or synovitis, and all joints were normal in 11 patients. Of the 11 participants, 54.5% developed abnormalities and 28.1% of normal joints at baseline became abnormal during the follow-up. Ankles were the most severely affected and had persistent progression during late adolescence and adulthood. Elbows and knees did not show progression after the first few years of the follow-up. The progression of haemophilic arthropathy in adolescents and young adults varies from individual to individual and also in the site of affected joints. In view of this, the decision regarding discontinuation of prophylaxis in patients with haemophilia should be individualized.

Citing Articles

Young adult outcomes of childhood prophylaxis for severe hemophilia A: results of the Joint Outcome Continuation Study.

Warren B, Thornhill D, Stein J, Fadell M, Ingram J, Funk S Blood Adv. 2020; 4(11):2451-2459.

PMID: 32492157 PMC: 7284094. DOI: 10.1182/bloodadvances.2019001311.


Controlled, cross-sectional MRI evaluation of joint status in severe haemophilia A patients treated with prophylaxis vs. on demand.

Oldenburg J, Zimmermann R, Katsarou O, Theodossiades G, Zanon E, Niemann B Haemophilia. 2014; 21(2):171-179.

PMID: 25470205 PMC: 4359687. DOI: 10.1111/hae.12539.


Physical and psychosocial challenges in adult hemophilia patients with inhibitors.

duTreil S J Blood Med. 2014; 5:115-22.

PMID: 25093002 PMC: 4114907. DOI: 10.2147/JBM.S63265.


Need for Prophylactic Treatment in Adult Haemophilia A Patients.

Siegmund B, Richter H, Pollmann H Transfus Med Hemother. 2010; 36(4):283-288.

PMID: 20877667 PMC: 2941834. DOI: 10.1159/000225965.